Investor Relations Press Releases Mar 20, 2023 Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System Mar 06, 2023 Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference Investor Fact Sheet Investor Fact Sheet Events & Presentations More information is coming soon. View all press releases + View all events & presentations + Intra 3 mo. 6 mo. 1 yr. Data Provided by Refinitiv. Minimum 15 minutes delayed. SEC Filings Filing date Form Description View Mar 2, 2023 8-K Report of unscheduled material events or corporate event View HTML 0001437749-23-005228.pdf 0001437749-23-005228.rtf 0001437749-23-005228.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Feb 21, 2023 8-K Report of unscheduled material events or corporate event View HTML 0001437749-23-003916.pdf 0001437749-23-003916.rtf 0001437749-23-003916.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Jan 12, 2023 8-K Report of unscheduled material events or corporate event View HTML 0001437749-23-000958.pdf 0001437749-23-000958.rtf 0001437749-23-000958.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View all SEC filings + Corporate Governance Documents Document View Audit Committee Charter Audit Committee Charter 129.4 KB Compensation Committee Charter Compensation Committee Charter 119.5 KB Corporate Governance and Nominating Committee Charter Corporate Governance and Nominating Committee Charter 119 KB Code of Business Conduct and Ethics Code of Business Conduct and Ethics 329.4 KB Communications with the Board Communications with the Board 7.9 KB
Mar 20, 2023 Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System
